600 Demographic characteristics and treatment changes in people with cystic fibrosis in 2019 and 2022: a single-center experience von Emran, J., Yeley, J., Brown, C.

Volltext

172 Treatment changes and outcomes in adults taking elexacaftor/tezacaftor/ivacaftor at two years: A single-center experience von Azeem, Q., Yeley, J., Vogt, H., Powers, C., Brown, C.

Volltext

438 Advanced practice providers in U.S. cystic fibrosis centers: current state of practice von Bichl, S., Brady, C., Dunitz, J., Dykes, S., George, C., Hamilton, J., Willey-Courand, D., Katz, L., Gifford, L., Yeley, J., Brown, R.

Volltext

Genetic Modifiers of Liver Disease in Cystic Fibrosis von Bartlett, Jaclyn R, Friedman, Kenneth J, Ling, Simon C, Pace, Rhonda G, Bell, Scott C, Bourke, Billy, Castaldo, Giuseppe, Castellani, Carlo, Cipolli, Marco, Colombo, Carla, Colombo, John L, Debray, Dominique, Fernandez, Adriana, Lacaille, Florence, Macek, Milan, Rowland, Marion, Salvatore, Francesco, Taylor, Christopher J, Wainwright, Claire, Wilschanski, Michael, Zemková, Dana, Hannah, William B, Phillips, M. James, Corey, Mary, Zielenski, Julian, Dorfman, Ruslan, Wang, Yunfei, Zou, Fei, Silverman, Lawrence M, Drumm, Mitchell L, Wright, Fred A, Lange, Ethan M, Durie, Peter R, Knowles, Michael R, Gene Modifier Study Group, for the

Volltext

Mar Menor lagoon (SE Spain) chlorophyll-a and turbidity estimation with Sentinel-2 von Zhan, Y, Delegido, J, Erena, M, Soria, JM, Ruiz-Verdú, A, Urrego, P, Sòria-Perpinyà, X, Vicente, E, Moreno, J

Volltext